Skip to main content

Table 3 Demographic and pre-treatment clinical variables according to type of transfusions given in those ≤50 years of age.

From: A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]

 

ABO Matched, Leukoreduced

ABO Matched, Leukoreduced, Washed

P value by Mann Whitney or Fisher's Exact Test

N

10

12

 

Age

30 ± 9.4

32 ± 9.5

0.77

Male

5 (50%)

6 (50%)

1.00

ALL/AML

1/9

4/8

0.32

Antecedent Hematologic Disorder (MDS)

0 of 10 (0%)

0 of 12 (0%)

1.00

Favorable Risk Cytogenetics

0 (0%)

0 (0%)

0.09

Standard Risk Cytogenetics

5 (33%)

2 (28%)

 

Poor Risk Cytogenetics

1 (11%)

6 (44%)

 

Unknown Cytogenetics

4 (50%)

4 (28%)

 

Admission Blast Count (×1000/μl)

29 ± 49

29 ± 49

0.56

  1. All data are mean ± 1 SD. MDS = myelodysplastic syndrome